Why Compliant Companies Are Often Functionally Opaque

Fact-anchored reassurance, over enough quarters, turns into something the market starts calling transparency. That is the operational claim running from The Bedrock of Investor Communication through its flagship companion What Reassurance Actually Costs, and the easiest one in the series to nod at and then ignore. This piece is about what happens when you ignore it in a particular regional way.

A listed company in Indonesia discloses everything OJK requires. Quarterly financials clear PSAK. Material events file inside the IDX window. Sustainability reporting tracks the most recent OJK Circular Letter. Audit-committee minutes show up on time. Independent commissioners’ fees appear, line by line, in the annual report.

A foreign institutional investor reviews the same company and, inside an hour, decides not to invest. She cannot point to a specific compliance failure, because there isn’t one. She describes the company as opaque and moves on.

She is right. The company is opaque. The opacity is invisible from inside, because every disclosure obligation the regulator considers material has been met. The gap between we have disclosed everything we must and investors feel they understand this company is the territory this essay maps.

The diagnosis is straightforward. Compliance is not transparency. Two different operations, two different owners, two different decision rules. Asian listed companies that conflate them, which is most of them, pay a quiet, compounding cost they never see itemised.

The asymmetric test

Transparency, in the operationally useful sense, has a specific test.

Does the company disclose specifics about unfavourable matters under no regulatory obligation to do so?

The test is deliberately asymmetric. A company that aggressively discloses favourable specifics (production beats, margin gains, contract wins, awards, ESG-rating upgrades) and stays silent on equivalent unfavourable specifics (margin compression drivers, contract renegotiations, capex misses, ratings downgrades, regulatory inquiries) is regulatorily compliant. It is also functionally opaque.

Asymmetric practice produces an asymmetric signal. Investors who compare the favourable-disclosure density to the unfavourable-disclosure density of a company over time read the ratio as a quality marker. A company whose disclosures lean steadily favourable carries a disbelief tax in everything it subsequently says. The working assumption becomes: whatever this company says will be either favourable or already required. The assumption is corrosive of trust precisely because, structurally, it is accurate.

The test is also operationally precise. For any given quarter, the company knows about a set of unfavourable specifics, margin pressures, customer issues, regulatory risk, capex slippage, executive transitions, that fall below the legally mandated disclosure threshold. Some fraction get disclosed voluntarily. That fraction is the transparency index. A fraction near zero is opacity dressed in compliance. A fraction near one is transparency.

In our advisory work, Asian listed companies rarely score above 0.2. Most do not know the index exists. Foreign investors compute it anyway.

Why compliance and transparency are not the same operation

Different organisational owners. Different decision rules. Different cost structures.

Compliance sits with legal and the corporate secretary. The question is: what must we disclose? The cost structure points one way. Failing to disclose what is required risks litigation and sanctions. Disclosing more than required carries no protective benefit. The compliance function, optimised correctly, minimises voluntary disclosure.

Transparency sits with IR and the CFO. The question is: what would help investors price this company more accurately? The cost structure points the other way. Investors who feel they cannot price the company accurately apply a discount. The discount cannot be seen one disclosure at a time; it compounds across many. The IR function, optimised correctly, maximises voluntary disclosure of anything material to accurate pricing.

In well-governed companies, the two functions cooperate. In most companies, they don’t. Compliance dominates because it owns a regulatory consequence that someone, somewhere, will write a memo about. IR does not own the pricing consequence in a way the board can see.

The default settles where you’d expect. Minimum-information disclosure that satisfies the regulator and underinforms the investor. Both objectives are achievable at once. You just have to design for both. Most companies don’t.

The same gap, found from every direction

What makes the diagnosis hard to dismiss is how many different starting points lead to it.

The trust-and-licence tradition treats transparency as the mechanism through which companies keep their social licence to operate, and the mechanism is not disclose the minimum required but demonstrate the willingness to disclose what is uncomfortable. Eccles documents the information gap directly: a persistent space between what regulators require and what investors actually need to price a specific company, and one that regulation alone cannot close, because regulation operates against the wrong incentive surface. The internet-era update sharpens the point further. Investors now have text analytics, social-media signals, and third-party data sitting next to whatever the company chooses to disclose, so opacity isn’t a vacuum. It’s a vacuum that other narratives flow into.

Bragg writes about the institutional plumbing: a properly constituted disclosure committee changes which question gets answered when a release goes out. Loranger and Nielsen’s eye-tracking work captures the reader-side cost: digital readers detect evasion within milliseconds and disengage well before any market reaction.

Different jurisdictions, different disciplines, same diagnosis. Compliance-floor disclosure leaves an information gap that investors price.

One voice deserves its own section.

Yorozu and the honne-tatemae frame

Yorozu’s institutional analysis of Japanese listed-company IR practice is the one that names what the others describe.

Honne is the inner truth: what the company actually knows about its operations, its risks, its commitments, its competitive position. Tatemae is the outer presentation: what gets disclosed to investors, regulators, employees, and the public. Both are real. Both are institutionally legitimate in Japanese corporate culture, and, by extension, much of East and Southeast Asian corporate culture. The gap between them is not, on its face, a failure. It is the default operating condition of corporate communication in the region.

The problem arises when the gap operates over many quarters. Each quarter, the company decides what fraction of the honne to surface as tatemae. The decisions accumulate. The disclosed narrative develops momentum. Internal operational reality shifts. The disclosed narrative drifts further from operational reality. Nobody inside notices the drift, because each individual decision was, in isolation, defensible, a perfectly reasonable choice of which specifics to volunteer this quarter, made by people acting in good faith.

Then a quarter arrives where operational reality cannot be reconciled with the disclosed narrative. An earnings miss too large to hide. A regulatory action. A strategic reversal. A customer loss. A writedown. The reconciliation happens in public. The cumulative gap closes in a single quarter, with the share-price reaction roughly proportional to how wide the gap had grown. Investors who had been operating with the tatemae update their models against the honne. The credibility cost, accumulated quarter by quarter, gets paid all at once.

Yorozu documents the pattern in Japanese listed companies through detailed case work; anyone advising across Korean, Indonesian, Malaysian, or Thai issuers will recognise it on sight. Her contribution is the institutional framing. The pattern is not random misconduct or particular bad actors. It is the structural consequence of a disclosure default that prefers indirection.

The Western reading of the pattern, that companies are “hiding bad news”, misses the mechanism. The companies are not hiding bad news in any active sense. They are operating within a disclosure default that does not require surfacing bad news that falls below the regulatory threshold. The cultural and institutional comfort with that default produces the gap. The empirical evidence establishes that the gap is expensive.

Of everything in this essay, honne-tatemae is the concept worth carrying back into the building. It is the one your CFO will recognise immediately, and the one most likely to start a productive argument inside the disclosure-committee meeting that you should probably also be running.

How foreign investors read the asymmetry

Sophisticated institutional investors compute the transparency index implicitly. Three mechanisms run in parallel.

The first is text analytics over disclosed materials. Quantitative funds, and increasingly long-only asset managers, run sentiment, hedge density, and qualifier-ratio analysis over earnings releases, conference-call transcripts, and annual-report MD&A. This is no longer exotic: vendors such as S&P now sell machine-readable transcript-sentiment scores as a standard dataset, built to drop straight into a stock-selection model. A company whose disclosures lean favourable relative to peers, or whose hedge density runs hot, scores poorly on those measures — and the score increasingly reaches the desk alongside the materials a human analyst eventually reads, rather than waiting on that analyst’s verdict. The company never sees the score computed. The IRO reviewing the quarter’s meeting log notices the inbound from London has tailed off and cannot say why; part of the answer is sitting in a vendor’s NLP pipeline.

The second is cross-document consistency. Investors comparing the website, fact sheet, deck, and earnings release for the same period flag inconsistencies as a quality signal. Asymmetric disclosure produces inconsistencies almost mechanically. A fact-sheet update mentions a positive operational metric the corresponding earnings release omitted. A deck slide claims a commercial milestone the website doesn’t yet reflect. The pattern reads as opacity even when no individual omission would, on its own.

The third is time-series tracking. Investors who have followed a company for several years build implicit baselines. A company that discloses unfavourable specifics in rough proportion to its actual operational variability accumulates trust. A company whose disclosures are always favourable, regardless of operational reality, accumulates scepticism. The scepticism is priced into the multiple before any specific event triggers a re-rating.

Together these mean that opacity is not invisible to investors, even when it is invisible to the company. The cost of compliance-only disclosure is paid in pricing rather than in regulatory action. Which is why the company never sees the bill.

The disclosure-committee architecture

Bragg’s contribution is the institutional fix. Companies that want to operate above the regulatory floor without ad-hoc judgement calls need a disclosure committee that:

• Includes the CFO, IRO, General Counsel, Corporate Secretary, and one senior independent board member.
• Meets in advance of every major disclosure event with a structured agenda covering required and discretionary items.
• Operates under a written charter that explicitly addresses voluntary-disclosure policy alongside required-disclosure compliance.
• Maintains a running log of disclosure decisions, including items considered for voluntary disclosure and the rationale for inclusion or exclusion.

The architecture changes the default. Without the committee, the disclosure decision sits with legal under what must we disclose? With the committee, it sits jointly and answers a different question: what is most useful for accurate pricing of this company?

Most of the region’s issuers do not have a disclosure committee in this sense. Many have one in name that operates as a compliance signoff. The gap between formal architecture and operating reality is its own diagnostic. A company that names a committee but does not run it according to charter has the form without the function, which is its own quiet variety of tatemae.

This committee will come up again. The closing essay in this body of work, Materiality Is a Choice, Not a Calculation, returns to it with a harder question: not whether the committee meets, but what it decides to call material when it does.

The Asian opportunity

Apply the asymmetric test across Asian listed-company peer sets and the pattern is striking. Almost no companies pass. Foreign-investor flows in Indonesia, Vietnam, the Philippines, and second-tier ASEAN markets are increasingly concentrated in the small set of companies that have crossed the transparency threshold. The crossing-companies tend to be large-cap, often dual-listed, often advised by international IR practitioners running an explicit transparency programme.

The thinness of the field is the opportunity. A company that builds a real transparency programme (disclosure committee with proper architecture, voluntary-disclosure policy in writing, asymmetric-test discipline applied to every release, time-series tracking of the unfavourable-disclosure ratio) becomes one of the small number of regional companies foreign investors can price with confidence.

It never appears on the income statement. It appears in the multiple.

The premium is hard to measure precisely and easy to observe. In the regional peer sets we work across, transparency-disciplined companies trade at a visible premium to opaque-by-default companies of similar sector and size — often a turn or two of P/E, depending on how much foreign-investor weight sits in the marginal pricing of the stock. The spread compounds across financing events, M&A discussions, and governance evaluations. The discipline costs operationally trivial amounts to implement. The premium it generates is not.

Building the transparency programme

In implementation order:

The five-step path takes a year to embed. The premium begins to accrue around the third or fourth quarter, once foreign investors have observed the pattern stabilise. None of that is fast by the standards of an executive looking for a re-rating before the next strategy review, which is part of why most companies will not do it.

The discount nobody itemises

The choice, compliance-only or transparency-disciplined, sits in the end with the disclosure committee — or, where no real committee exists, with whoever is making disclosure decisions by default. Nothing in the regulatory environment forces it either way. Everything in the institutional environment leans toward the floor: legal owns a consequence the board can see, cultural defaults reward indirection, and opacity never sends an invoice.

A company that chooses the programme accumulates a foreign-investor premium that builds with every reporting cycle, and a decision log peers cannot quickly replicate — the moat is the cumulative record of judgements, not the charter. Its pricing starts to reflect its operational substance rather than the visibility-to-investors discount that sits over the region. The opportunity is asymmetric in exactly the same direction as the test that defines it.

The discount, for everyone else, keeps accruing in the one place nobody itemises it. It never appears on the income statement. It appears in the multiple.

The next piece in this body of work, You Cannot Edit Your Way Out of Bad Analysis, takes the diagnostic apparatus inside the company. If the asymmetric test catches opacity from the outside, the bidirectional flabby-information test catches it from within: the entanglement between bad analysis and bad slides, and why polish fixes neither.